Inventor
CROOKS PETER ANTHONY
US20 patents
⚠️ This page may combine multiple inventors who share the name “CROOKS PETER ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TARGACEPT INC
8 patentsUS6958399B2Oct 25, 2005
Compounds capable of activating cholinergic receptors
TARGACEPT INC28 citations92
US6624173B1Sep 23, 2003
Pharmaceutical compositions for treating and/or preventing CNS disorders
TARGACEPT INC39 citations92
US6525065B1Feb 25, 2003
Pharmaceutical compositions and methods for effecting dopamine release
TARGACEPT INC24 citations92
US6417359B1Jul 9, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC33 citations92
US6432975B1Aug 13, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC19 citations84
US7307092B2Dec 11, 2007
Compounds Capable of Activating Cholinergic Receptors
TARGACEPT INC9 citations73
US7060826B2Jun 13, 2006
Compounds capable of activating cholinergic receptors
TARGACEPT INC10 citations73
US7790757B2Sep 7, 2010
Compounds capable of activating cholinergic receptors
TARGACEPT INC0 citations51
UNIV KENTUCKY RES FOUND
5 patentsUS6051576AApr 18, 2000
Means to achieve sustained release of synergistic drugs by conjugation
UNIV KENTUCKY RES FOUND637 citations96
US10668030B2Jun 2, 2020
Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
UNIV KENTUCKY RES FOUND10 citations80
US7759468B1Jul 20, 2010
Bioactive peptide-based probes
UNIV KENTUCKY RES FOUND4 citations60
US11999676B2Jun 4, 2024
Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
UNIV KENTUCKY RES FOUND1 citations56
US10071982B2Sep 11, 2018
Method of treating neuropathic pain
UNIV KENTUCKY RES FOUND0 citations48
(unassigned)
4 patentsUS5726316AMar 10, 1998
Pharmaceutical compositions for prevention and treatment of central nervous system disorders
98 citations96
US6057446AMay 2, 2000
Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
20 citations92
US5986100ANov 16, 1999
Pharmaceutical compositions and methods for use
14 citations79
US6211372B1Apr 3, 2001
Pharmaceutical compositions and methods for use
6 citations71
MITOCHON PHARMACEUTICALS INC
2 patentsUS10548900B2Feb 4, 2020
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
MITOCHON PHARMACEUTICALS INC1 citations68
US11406642B2Aug 9, 2022
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
MITOCHON PHARMACEUTICALS INC0 citations58